| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5624057 | Alzheimer's & Dementia | 2015 | 11 Pages |
Abstract
[18F]flutemetamol amyloid PET detects primarily advanced stages of Aβ pathology in preclinical and symptomatic AD cases.
Related Topics
Life Sciences
Neuroscience
Neurology
![[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology](/preview/png/5624057.png "First Page Preview: [18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology")
Authors
Dietmar Rudolf Thal, Thomas G. Beach, Michelle Zanette, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Adrian P.L. Smith, Christopher Buckley,